These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The public health impact of anxiety disorders: a WHO perspective. Costa e Silva JA Acta Psychiatr Scand Suppl; 1998; 393():2-5. PubMed ID: 9777040 [TBL] [Abstract][Full Text] [Related]
26. Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies. Wittchen HU; Jacobi F Eur Neuropsychopharmacol; 2005 Aug; 15(4):357-76. PubMed ID: 15961293 [TBL] [Abstract][Full Text] [Related]
27. The epidemiology of generalized anxiety disorder in Europe. Lieb R; Becker E; Altamura C Eur Neuropsychopharmacol; 2005 Aug; 15(4):445-52. PubMed ID: 15951160 [TBL] [Abstract][Full Text] [Related]
28. Cost of trauma in Europe. Berg J; Tagliaferri F; Servadei F Eur J Neurol; 2005 Jun; 12 Suppl 1():85-90. PubMed ID: 15877786 [No Abstract] [Full Text] [Related]
29. [Anxiety disorders in adolescents and young adults]. Ranta K; Kaltiala-Heino R; Rantanen P; Pelkonen M; Marttunen M Duodecim; 2001; 117(12):1225-32. PubMed ID: 12183924 [No Abstract] [Full Text] [Related]
30. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study. Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874 [TBL] [Abstract][Full Text] [Related]
31. The epidemiology of anxiety disorders: prevalence and societal costs. Lépine JP J Clin Psychiatry; 2002; 63 Suppl 14():4-8. PubMed ID: 12562112 [TBL] [Abstract][Full Text] [Related]
32. DSM-5 proposals for mood disorders: a cost-benefit analysis. First MB Curr Opin Psychiatry; 2011 Jan; 24(1):1-9. PubMed ID: 21042219 [TBL] [Abstract][Full Text] [Related]
33. The burden of illness associated with renal cell carcinoma in the United States. Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652 [TBL] [Abstract][Full Text] [Related]
34. Developing a European research network to address unmet needs in anxiety disorders. Baldwin DS; Pallanti S; Zwanzger P Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2312-7. PubMed ID: 23313646 [TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up. Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P; J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089 [TBL] [Abstract][Full Text] [Related]
36. Mental health treatment and the reduction of health care costs: a four-year study of U.S. Federal employees enrollment with the Aetna Life Insurance Company. Holder HD; Blose JO Adv Health Econ Health Serv Res; 1987; 8():157-74. PubMed ID: 10292339 [No Abstract] [Full Text] [Related]
37. Economics of anxiety and depression. Introduction. Moscarelli M Br J Psychiatry Suppl; 1995 Apr; (27):7-9. PubMed ID: 7794596 [No Abstract] [Full Text] [Related]
38. Comprehensive review of generalized anxiety disorder in primary care in Europe. Parmentier H; García-Campayo J; Prieto R Curr Med Res Opin; 2013 Apr; 29(4):355-67. PubMed ID: 23356728 [TBL] [Abstract][Full Text] [Related]
39. Performance of statistical models to predict mental health and substance abuse cost. Montez-Rath M; Christiansen CL; Ettner SL; Loveland S; Rosen AK BMC Med Res Methodol; 2006 Oct; 6():53. PubMed ID: 17067394 [TBL] [Abstract][Full Text] [Related]
40. Completeness of response and quality of life in mood and anxiety disorders. Meltzer-Brody S; Davidson JR Depress Anxiety; 2000; 12 Suppl 1():95-101. PubMed ID: 11098422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]